Kursinformation
Für dieses Unternehmen ist kein Kurs-Chart verfügbar.
()
Aktuelle News
News Funktionen
Weitere Funktionen
21 Dezember 2023
10:00
Corporate
EN
invIOs GmbH
Corporate
EN
invIOs to attend JP Morgan Week in San Francisco in January
9 November 2023
11:30
Corporate
EN
invIOs GmbH
Corporate
EN
invIOs and Dana-Farber Cancer Institute start collaboration to study novel small molecule INV501 for treatment of glioblastoma
5 September 2023
09:00
Corporate
EN
invIOs GmbH
Corporate
EN
invIOs starts further clinical trial of APN401, novel cell therapy against solid cancers, and secures major Austrian grant funding
19 Juni 2023
14:30
Corporate
EN
invIOs GmbH
Corporate
EN
invIOs presents exciting preclinical data showing that immune-activating small molecule INV501 induces strong cytotoxic activity against solid tumors
18 April 2023
15:00
Corporate
EN
invIOs GmbH
Corporate
EN
invIOs presents promising new clinical data in solid tumors from autologous cell therapy APN401 at AACR Annual Meeting 2023
14 Dezember 2022
14:00
Corporate
EN
invIOs GmbH
Corporate
EN
invIOs to present at Biotech Showcase